Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenac
Bromfenac sodium
Bromfenaco
Bromfenacum
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Brand Names
Yellox
Xibrom
Bromfenac Ophthalmic Solution 0.09%
Bromfenac
Bromday
Prolensa
Apo-bromfenac
Pred Phos-Gati-Brom
Bromfenac 0.075%
Auro-bromfenac
Bromsite 0.075%
Bromfenac Sodium
Pred-Brom
Pred-Gati-Brom
Bromfenac Ophthalmic Solution, 0.09%
Bromfenac Ophthalmic Solution
Pred Phos - Brom
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682